{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:29:59Z","timestamp":1793852999926,"version":"4.6.1"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100013790","name":"Brain Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR-CS-011-028"],"award-info":[{"award-number":["NIHR-CS-011-028"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dutch Brain Foundation"},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104612\/Z\/14\/Z"],"award-info":[{"award-number":["104612\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K015184\/1"],"award-info":[{"award-number":["MR\/K015184\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Joules Thorn Trust","award":["Sir Jules Thorn Award for Biomedical Science"],"award-info":[{"award-number":["Sir Jules Thorn Award for Biomedical Science"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Migraine is a highly prevalent disorder with significant economical and personal burden. Despite the development of effective therapeutics, the causes which precipitate migraine attacks remain elusive. Clinical studies have highlighted altered metabolic flux and mitochondrial function in patients. In vivo animal experiments can allude to the metabolic mechanisms which may underlie migraine susceptibility. Understanding the translational relevance of these studies are important to identifying triggers, biomarkers and therapeutic targets in migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>Functional imaging studies have suggested that migraineurs feature metabolic syndrome, exhibiting hallmark features including upregulated oxidative phosphorylation yet depleted available free energy. Glucose hypometabolism is also evident in migraine patients and can lead to altered neuronal hyperexcitability such as the incidence of cortical spreading depression (CSD). The association between obesity and increased risk, frequency and worse prognosis of migraine also highlights lipid dysregulation in migraine pathology. Calcitonin gene related peptide (CGRP) has demonstrated an important role in sensitisation and nociception in headache, however its role in metabolic regulation in connection with migraine has not been thoroughly explored. Whether impaired metabolic function leads to increased release of peptides such as CGRP or excessive nociception leads to altered flux is yet unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Migraine susceptibility may be underpinned by impaired metabolism resulting in depleted energy stores and altered neuronal function. This review discusses both clinical and in vivo studies which provide evidence of altered metabolic flux which contribute toward pathophysiology. It also reviews the translational relevance of animal studies in identifying targets of biomarker or therapeutic development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-022-01494-w","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:04:02Z","timestamp":1664492642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Alterations in metabolic flux in migraine and the translational relevance"],"prefix":"10.1186","volume":"23","author":[{"given":"Olivia","family":"Grech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Sassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Terwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth G.","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan P.","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"issue":"10159","key":"1494_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/s0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789\u2013858. https:\/\/doi.org\/10.1016\/s0140-6736(18)32279-7","journal-title":"Lancet"},{"key":"1494_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-14-1","volume":"14","author":"TJ Steiner","year":"2013","unstructured":"Steiner TJ, Stovner LJ, Birbeck GL (2013) Migraine: the seventh disabler. J Headache Pain 14:1\u20131. https:\/\/doi.org\/10.1186\/1129-2377-14-1","journal-title":"J Headache Pain"},{"issue":"5","key":"1494_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1212\/WNL.55.5.629","volume":"55","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression. Neurol 55(5):629. https:\/\/doi.org\/10.1212\/WNL.55.5.629","journal-title":"Neurol"},{"issue":"9","key":"1494_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1526-4610.2006.00576.x","volume":"46","author":"SW Hamelsky","year":"2006","unstructured":"Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of migraine. Headache 46(9):1327\u20131333. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00576.x","journal-title":"Headache"},{"issue":"1","key":"1494_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12883-020-01633-3","volume":"20","author":"H Deng","year":"2020","unstructured":"Deng H, Li G-g, Nie H, Feng Y-y, Guo G-y, Guo W-l et al (2020) Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine \u2013 an updated systematic review and meta-analysis. BMC Neurol 20(1):57. https:\/\/doi.org\/10.1186\/s12883-020-01633-3","journal-title":"BMC Neurol"},{"issue":"1","key":"1494_CR6","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1038\/s41598-022-08206-z","volume":"12","author":"A Terrin","year":"2022","unstructured":"Terrin A, Bello L, Valentino ML, Caporali L, Sorar\u00f9 G, Carelli V et al (2022) The relevance of migraine in the clinical spectrum of mitochondrial disorders. Sci Rep 12(1):4222. https:\/\/doi.org\/10.1038\/s41598-022-08206-z","journal-title":"Sci Rep"},{"issue":"2","key":"1494_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/NRL.0b013e31817781b6","volume":"15","author":"B Guldiken","year":"2009","unstructured":"Guldiken B, Guldiken S, Taskiran B, Koc G, Turgut N, Kabayel L et al (2009) Migraine in metabolic syndrome. Neurologist 15(2):55\u201358. https:\/\/doi.org\/10.1097\/NRL.0b013e31817781b6","journal-title":"Neurologist"},{"issue":"Suppl 1","key":"1494_CR8","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.4103\/0972-2327.100015","volume":"15","author":"AJ Sinclair","year":"2012","unstructured":"Sinclair AJ, Matharu M (2012) Migraine, cerebrovascular disease and the metabolic syndrome. Ann Indian Acad Neurol 15(Suppl 1):S72\u2013S77. https:\/\/doi.org\/10.4103\/0972-2327.100015","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"1494_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/life11050415","volume":"11","author":"O Grech","year":"2021","unstructured":"Grech O, Mollan SP, Wakerley BR, Fulton D, Lavery GG, Sinclair AJ (2021) The Role of Metabolism in Migraine Pathophysiology and Susceptibility. Life. 11(5):415. https:\/\/doi.org\/10.3390\/life11050415","journal-title":"Life."},{"issue":"4","key":"1494_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine\u2013current understanding and treatment. N Engl J Med 346(4):257\u2013270. https:\/\/doi.org\/10.1056\/NEJMra010917","journal-title":"N Engl J Med"},{"issue":"1","key":"1494_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1129-2377-14-71","volume":"14","author":"S Benemei","year":"2013","unstructured":"Benemei S, De Cesaris F, Fusi C, Rossi E, Lupi C, Geppetti P (2013) TRPA1 and other TRP channels in migraine. J Headache Pain 14(1):71. https:\/\/doi.org\/10.1186\/1129-2377-14-71","journal-title":"J Headache Pain"},{"issue":"15","key":"1494_CR12","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1523\/jneurosci.5490-08.2009","volume":"29","author":"J Meng","year":"2009","unstructured":"Meng J, Ovsepian SV, Wang J, Pickering M, Sasse A, Aoki KR et al (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 29(15):4981\u20134992. https:\/\/doi.org\/10.1523\/jneurosci.5490-08.2009","journal-title":"J Neurosci"},{"issue":"16","key":"1494_CR13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/01.WNL.0000286940.29755.61","volume":"70","author":"TW Ho","year":"2008","unstructured":"Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ et al (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurol 70(16):1304. https:\/\/doi.org\/10.1212\/01.WNL.0000286940.29755.61","journal-title":"Neurol"},{"issue":"6","key":"1494_CR14","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1177\/0333102411398399","volume":"31","author":"DJ Hewitt","year":"2011","unstructured":"Hewitt DJ, Aurora SK, Dodick DW, Goadsby PJ, Ge Y, Bachman R et al (2011) Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia 31(6):712\u2013722. https:\/\/doi.org\/10.1177\/0333102411398399","journal-title":"Cephalalgia"},{"issue":"11","key":"1494_CR15","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350(11):1104\u20131110. https:\/\/doi.org\/10.1056\/NEJMoa030505","journal-title":"N Engl J Med"},{"issue":"11","key":"1494_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M et al (2014) Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol 13(11):1100\u20131107. https:\/\/doi.org\/10.1016\/S1474-4422(14)70209-1","journal-title":"Lancet Neurol"},{"issue":"9","key":"1494_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW, Goadsby PJ, Spierings ELH, Scherer JC, Sweeney SP, Grayzel DS (2014) Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol 13(9):885\u2013892. https:\/\/doi.org\/10.1016\/S1474-4422(14)70128-0","journal-title":"Lancet Neurol"},{"issue":"8","key":"1494_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tins.2012.04.007","volume":"35","author":"D Vecchia","year":"2012","unstructured":"Vecchia D, Pietrobon D (2012) Migraine: a disorder of brain excitatory\u2013inhibitory balance? Trends Neurosci 35(8):507\u2013520","journal-title":"Trends Neurosci"},{"issue":"2","key":"1494_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1152\/physrev.00034.2015","volume":"97","author":"PJ Goadsby","year":"2017","unstructured":"Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553\u2013622. https:\/\/doi.org\/10.1152\/physrev.00034.2015","journal-title":"Physiol Rev"},{"issue":"8","key":"1494_CR20","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1073\/pnas.071582498","volume":"98","author":"N Hadjikhani","year":"2001","unstructured":"Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B et al (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98(8):4687\u20134692. https:\/\/doi.org\/10.1073\/pnas.071582498","journal-title":"Proc Natl Acad Sci USA"},{"key":"1494_CR21","doi-asserted-by":"publisher","unstructured":"Leao AAP, (1944) SPREADING DEPRESSION OF ACTIVITY IN THE CEREBRAL CORTEX. J Neurophysiology, 7, 359\u2013390. https:\/\/doi.org\/10.1152\/jn.1944.7.6.359.","DOI":"10.1152\/jn.1944.7.6.359"},{"issue":"5","key":"1494_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/ana.1293","volume":"50","author":"SM Bowyer","year":"2001","unstructured":"Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM (2001) Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 50(5):582\u2013587. https:\/\/doi.org\/10.1002\/ana.1293","journal-title":"Ann Neurol"},{"issue":"9","key":"1494_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache classification committee of the international headache S","year":"2013","unstructured":"Headache classification committee of the international headache S (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629\u2013808. https:\/\/doi.org\/10.1177\/0333102413485658","journal-title":"Cephalalgia"},{"issue":"26","key":"1494_CR24","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"X Zhang","year":"2010","unstructured":"Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci\u202f: J Soc Neurosci 30(26):8807\u20138814. https:\/\/doi.org\/10.1523\/JNEUROSCI.0511-10.2010","journal-title":"J Neurosci : J Soc Neurosci"},{"issue":"8","key":"1494_CR25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s11064-021-03335-9","volume":"46","author":"JM Borkum","year":"2021","unstructured":"Borkum JM (2021) Brain energy deficit as a source of oxidative stress in migraine: a molecular basis for migraine susceptibility. Neurochem Res 46(8):1913\u20131932. https:\/\/doi.org\/10.1007\/s11064-021-03335-9","journal-title":"Neurochem Res"},{"issue":"4","key":"1494_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/jnr.490220413","volume":"22","author":"DZ Gerhart","year":"1989","unstructured":"Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR (1989) Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 22(4):464\u2013472. https:\/\/doi.org\/10.1002\/jnr.490220413","journal-title":"J Neurosci Res"},{"issue":"10","key":"1494_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/ars.2015.6593","volume":"25","author":"R Mongeon","year":"2016","unstructured":"Mongeon R, Venkatachalam V, Yellen G (2016) Cytosolic NADH-NAD+ redox visualized in brain slices by two-photon fluorescence lifetime biosensor imaging. Antioxid Redox Signal 25(10):553\u2013563","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"1494_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/jnr.24374","volume":"97","author":"CM D\u00edaz-Garc\u00eda","year":"2019","unstructured":"D\u00edaz-Garc\u00eda CM, Yellen G (2019) Neurons rely on glucose rather than astrocytic lactate during stimulation. J Neurosci Res 97(8):883\u2013889. https:\/\/doi.org\/10.1002\/jnr.24374","journal-title":"J Neurosci Res"},{"issue":"2","key":"1494_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/jcbfm.2012.132","volume":"33","author":"U Hoffmann","year":"2013","unstructured":"Hoffmann U, Sukhotinsky I, Eikermann-Haerter K, Ayata C (2013) Glucose modulation of spreading depression susceptibility. J Cereb Blood Flow Metab\u202f: J Int Soc Cereb Blood Flow Metab 33(2):191\u2013195. https:\/\/doi.org\/10.1038\/jcbfm.2012.132","journal-title":"J Cereb Blood Flow Metab : J Int Soc Cereb Blood Flow Metab"},{"key":"1494_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1152\/jn.1960.23.3.225","volume":"23","author":"J Bures","year":"1960","unstructured":"Bures J, Buresova O (1960) Activation of latent foci of spreading cortical depression in rats. J Neurophysiol 23:225\u2013236. https:\/\/doi.org\/10.1152\/jn.1960.23.3.225","journal-title":"J Neurophysiol"},{"issue":"2","key":"1494_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0006-8993(76)90817-9","volume":"103","author":"J Astrup","year":"1976","unstructured":"Astrup J, Norberg K (1976) Potassium activity in cerebral cortex in rats during progressive severe hypoglycemia. Brain Res 103(2):418\u2013423. https:\/\/doi.org\/10.1016\/0006-8993(76)90817-9","journal-title":"Brain Res"},{"key":"1494_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nbd.2017.01.005","volume":"101","author":"M Martins-Oliveira","year":"2017","unstructured":"Martins-Oliveira M, Akerman S, Holland PR, Hoffmann JR, Tavares I, Goadsby PJ (2017) Neuroendocrine signaling modulates specific neural networks relevant to migraine. Neurobiol Dis 101:16\u201326. https:\/\/doi.org\/10.1016\/j.nbd.2017.01.005","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1494_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1212\/01.WNL.0000052998.58526.A9","volume":"60","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J et al (2003) Premonitory symptoms in migraine. Neurol 60(6):935. https:\/\/doi.org\/10.1212\/01.WNL.0000052998.58526.A9","journal-title":"Neurol"},{"issue":"4","key":"1494_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1037\/0278-6133.16.4.310","volume":"16","author":"PR Martin","year":"1997","unstructured":"Martin PR, Seneviratne HM (1997) Effects of food deprivation and a stressor on head pain. Health Psychol 16(4):310","journal-title":"Health Psychol"},{"issue":"12","key":"1494_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jpc.12613","volume":"50","author":"SS Mohammad","year":"2014","unstructured":"Mohammad SS, Coman D, Calvert S (2014) Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature. J Paediatr Child Health 50(12):1025\u20131026. https:\/\/doi.org\/10.1111\/jpc.12613","journal-title":"J Paediatr Child Health"},{"key":"1494_CR36","doi-asserted-by":"publisher","first-page":"679354","DOI":"10.3389\/fneur.2021.679354","volume":"12","author":"C Scoppola","year":"2021","unstructured":"Scoppola C, Magli G, Conti M, Fadda M, Luzzu GM, Simula DM et al (2021) CACNA1A-Linked hemiplegic migraine in GLUT 1 deficiency syndrome: a case report. Front Neurol 12:679354. https:\/\/doi.org\/10.3389\/fneur.2021.679354","journal-title":"Front Neurol"},{"issue":"1","key":"1494_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1468-2982.2009.01890.x","volume":"30","author":"JH Kim","year":"2010","unstructured":"Kim JH, Kim S, Suh SI, Koh SB, Park KW, Oh K (2010) Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia 30(1):53\u201361. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01890.x","journal-title":"Cephalalgia"},{"issue":"9","key":"1494_CR38","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/0333102416656118","volume":"37","author":"D Magis","year":"2017","unstructured":"Magis D, D\u2019Ostilio K, Thibaut A, De Pasqua V, Gerard P, Hustinx R et al (2017) Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia 37(9):881\u2013891. https:\/\/doi.org\/10.1177\/0333102416656118","journal-title":"Cephalalgia"},{"issue":"1","key":"1494_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s10194-021-01289-5","volume":"22","author":"M Torres-Ferrus","year":"2021","unstructured":"Torres-Ferrus M, Pareto D, Gallardo VJ, Cuberas-Borr\u00f3s G, Alpuente A, Caronna E et al (2021) Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18FDG-PET and MRI study. J Headache Pain 22(1):75. https:\/\/doi.org\/10.1186\/s10194-021-01289-5","journal-title":"J Headache Pain"},{"issue":"4","key":"1494_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrn.2018.19","volume":"19","author":"PJ Magistretti","year":"2018","unstructured":"Magistretti PJ, Allaman I (2018) Lactate in the brain: from metabolic end-product to signalling molecule. Nat Rev Neurosci 19(4):235\u2013249. https:\/\/doi.org\/10.1038\/nrn.2018.19","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"1494_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0304-3940(92)90141-s","volume":"135","author":"D Scheller","year":"1992","unstructured":"Scheller D, Kolb J, Tegtmeier F (1992) Lactate and pH change in close correlation in the extracellular space of the rat brain during cortical spreading depression. Neurosci Lett 135(1):83\u201386. https:\/\/doi.org\/10.1016\/0304-3940(92)90141-s","journal-title":"Neurosci Lett"},{"issue":"6","key":"1494_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nn1902","volume":"10","author":"T Takano","year":"2007","unstructured":"Takano T, Tian GF, Peng W, Lou N, Lovatt D, Hansen AJ et al (2007) Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci 10(6):754\u2013762. https:\/\/doi.org\/10.1038\/nn1902","journal-title":"Nat Neurosci"},{"issue":"11","key":"1494_CR43","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1177\/0271678x15612779","volume":"36","author":"D Feuerstein","year":"2016","unstructured":"Feuerstein D, Backes H, Gramer M, Takagaki M, Gabel P, Kumagai T et al (2016) Regulation of cerebral metabolism during cortical spreading depression. J Cereb Blood Flow Metab 36(11):1965\u20131977. https:\/\/doi.org\/10.1177\/0271678x15612779","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1494_CR44","doi-asserted-by":"publisher","first-page":"8202","DOI":"10.4081\/ejtm.2019.8202","volume":"29","author":"P Proia","year":"2019","unstructured":"Proia P, Amato A, Contr\u00f2 V, Monaco AL, Brusa J, Brighina F et al (2019) Relevance of lactate level detection in migrane and fibromyalgia. Eur J Trans Myol 29(2):8202. https:\/\/doi.org\/10.4081\/ejtm.2019.8202","journal-title":"Eur J Trans Myol"},{"issue":"1","key":"1494_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1526-4610.1998.3801039.x","volume":"38","author":"H Okada","year":"1998","unstructured":"Okada H, Araga S, Takeshima T, Nakashima K (1998) plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. headache: J Head Face Pain 38(1):39\u201342. https:\/\/doi.org\/10.1046\/j.1526-4610.1998.3801039.x","journal-title":"J Head Face Pain"},{"issue":"1","key":"1494_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10194-021-01285-9","volume":"22","author":"T Acz\u00e9l","year":"2021","unstructured":"Acz\u00e9l T, K\u00f6rt\u00e9si T, Kun J, Urb\u00e1n P, Bauer W, Herczeg R et al (2021) Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis. J Headache Pain 22(1):117. https:\/\/doi.org\/10.1186\/s10194-021-01285-9","journal-title":"J Headache Pain"},{"issue":"6","key":"1494_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.rbr.2015.02.002","volume":"55","author":"GACdS Ribeiro","year":"2015","unstructured":"Ribeiro GACdS, Scola RH, Piovesan EJ, Wollmann Junior DR, Paiva EdS, Cunha CLPd et al (2015) A import\u00e2ncia de \u00e1cido l\u00e1ctico na enxaqueca e na fibromialgia. Rev Bras Reumatol 55(6):471\u20136. https:\/\/doi.org\/10.1016\/j.rbr.2015.02.002","journal-title":"Rev Bras Reumatol"},{"issue":"5","key":"1494_CR48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1468-2982.2009.01979.x","volume":"30","author":"D Grimaldi","year":"2010","unstructured":"Grimaldi D, Tonon C, Cevoli S, Pierangeli G, Malucelli E, Rizzo G et al (2010) Clinical and neuroimaging evidence of interictal cerebellar dysfunction in FHM2. Cephalalgia 30(5):552\u2013559. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01979.x","journal-title":"Cephalalgia"},{"issue":"1\u20132","key":"1494_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jns.2008.04.004","volume":"271","author":"K Shibata","year":"2008","unstructured":"Shibata K, Yamane K, Otuka K, Iwata M (2008) Abnormal visual processing in migraine with aura: a study of steady-state visual evoked potentials. J Neurol Sci 271(1\u20132):119\u2013126. https:\/\/doi.org\/10.1016\/j.jns.2008.04.004","journal-title":"J Neurol Sci"},{"issue":"4","key":"1494_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1212\/wnl.47.4.1093","volume":"47","author":"H Watanabe","year":"1996","unstructured":"Watanabe H, Kuwabara T, Ohkubo M, Tsuji S, Yuasa T (1996) Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period. Neurol 47(4):1093\u20131095. https:\/\/doi.org\/10.1212\/wnl.47.4.1093","journal-title":"Neurol"},{"issue":"3","key":"1494_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10194-011-0295-7","volume":"12","author":"H Reyngoudt","year":"2011","unstructured":"Reyngoudt H, Paemeleire K, Dierickx A, Descamps B, Vandemaele P, De Deene Y et al (2011) Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional 1H-MRS study. J Headache Pain 12(3):295\u2013302. https:\/\/doi.org\/10.1007\/s10194-011-0295-7","journal-title":"J Headache Pain"},{"issue":"15","key":"1494_CR52","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e3182a824f7","volume":"81","author":"BL Peterlin","year":"2013","unstructured":"Peterlin BL, Rosso AL, Williams MA, Rosenberg JR, Haythornthwaite JA, Merikangas KR et al (2013) Episodic migraine and obesity and the influence of age, race, and sex. Neurol 81(15):1314. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a824f7","journal-title":"Neurol"},{"issue":"18","key":"1494_CR53","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1001\/archinte.167.18.1964","volume":"167","author":"ME Bigal","year":"2007","unstructured":"Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB et al (2007) Body mass index and episodic headaches: a population-based study. Arch Intern Med 167(18):1964\u20131970. https:\/\/doi.org\/10.1001\/archinte.167.18.1964","journal-title":"Arch Intern Med"},{"issue":"1","key":"1494_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3959(03)00293-8","volume":"106","author":"IA Scher","year":"2003","unstructured":"Scher IA, Stewart FW, Ricci AJ, Lipton BR (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. PAIN. 106(1):81","journal-title":"PAIN."},{"issue":"2","key":"1494_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1212\/01.wnl.0000225052.35019.f9","volume":"67","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurol 67(2):252. https:\/\/doi.org\/10.1212\/01.wnl.0000225052.35019.f9","journal-title":"Neurol"},{"issue":"4","key":"1494_CR56","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0196-9781(91)90147-H","volume":"12","author":"PM Zelissen","year":"1991","unstructured":"Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH (1991) Calcitonin gene-related peptide in human obesity. Peptides 12(4):861\u2013863","journal-title":"Peptides"},{"issue":"10","key":"1494_CR57","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1194\/jlr.M700021-JLR200","volume":"48","author":"A Nicolaysen","year":"2007","unstructured":"Nicolaysen A, Gammelsaeter R, Storm-Mathisen J, Gundersen V, Iversen PO (2007) The components required for amino acid neurotransmitter signaling are present in adipose tissues. J Lipid Res 48(10):2123\u20132132. https:\/\/doi.org\/10.1194\/jlr.M700021-JLR200","journal-title":"J Lipid Res"},{"issue":"4","key":"1494_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0404.1988.tb03656.x","volume":"78","author":"C Hedman","year":"1988","unstructured":"Hedman C, Winther K, Knudsen J (1988) Platelet function in classic migraine during attack-free periods. Acta Neurol Scand 78(4):271\u2013277","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"1494_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1468-1331.2009.02861.x","volume":"17","author":"HJ Gruber","year":"2010","unstructured":"Gruber HJ, Bernecker C, Pailer S, Lechner A, Horejsi R, M\u00f6ller R et al (2010) Lipid profile in normal weight migraineurs\u2013evidence for cardiovascular risk. Eur J Neurol 17(3):419\u2013425","journal-title":"Eur J Neurol"},{"issue":"14","key":"1494_CR60","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1177\/0333102411421682","volume":"31","author":"PM Rist","year":"2011","unstructured":"Rist PM, Tzourio C, Kurth T (2011) Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study. Cephalalgia 31(14):1459\u20131465. https:\/\/doi.org\/10.1177\/0333102411421682","journal-title":"Cephalalgia"},{"issue":"16","key":"1494_CR61","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007313","volume":"92","author":"GLJ Onderwater","year":"2019","unstructured":"Onderwater GLJ, Ligthart L, Bot M, Demirkan A, Fu J, van der Kallen CJH et al (2019) Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine. Neurol 92(16):e1899. https:\/\/doi.org\/10.1212\/WNL.0000000000007313","journal-title":"Neurol"},{"issue":"7","key":"1494_CR62","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/papr.12229","volume":"15","author":"C Tana","year":"2015","unstructured":"Tana C, Santilli F, Martelletti P, di Vincenzo A, Cipollone F, Dav\u00ec G et al (2015) Correlation between migraine severity and cholesterol levels. Pain Pract 15(7):662\u2013670","journal-title":"Pain Pract"},{"issue":"4","key":"1494_CR63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/01.WNL.0000151857.43225.49","volume":"64","author":"AI Scher","year":"2005","unstructured":"Scher AI, Terwindt GM, Picavet HSJ, Verschuren WMM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine. Neurol 64(4):614. https:\/\/doi.org\/10.1212\/01.WNL.0000151857.43225.49","journal-title":"Neurol"},{"issue":"1","key":"1494_CR64","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10072-016-2746-z","volume":"38","author":"X Hu","year":"2017","unstructured":"Hu X, Zhou Y, Zhao H, Peng C (2017) Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies. Neurol Sci 38(1):33\u201340","journal-title":"Neurol Sci"},{"issue":"3","key":"1494_CR65","doi-asserted-by":"publisher","first-page":"e020498","DOI":"10.1136\/bmjopen-2017-020498","volume":"8","author":"AN Mahmoud","year":"2018","unstructured":"Mahmoud AN, Mentias A, Elgendy AY, Qazi A, Barakat AF, Saad M et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8(3):e020498. https:\/\/doi.org\/10.1136\/bmjopen-2017-020498","journal-title":"BMJ Open"},{"issue":"3","key":"1494_CR66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/metabo12030220","volume":"12","author":"ICM Loonen","year":"2022","unstructured":"Loonen ICM, Kohler I, Ghorasaini M, Giera M, van den Maagdenberg A, Mayboroda OA et al (2022) Changes in plasma lipid levels following cortical spreading depolarization in a transgenic mouse model of familial hemiplegic migraine. Metabolites. 12(3):220. https:\/\/doi.org\/10.3390\/metabo12030220","journal-title":"Metabolites."},{"issue":"6","key":"1494_CR67","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/head.14125","volume":"61","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Grech O, Sinclair AJ (2021) Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review. Headache: J Head Face Pain 61(6):808\u201316. https:\/\/doi.org\/10.1111\/head.14125","journal-title":"J Head Face Pain"},{"issue":"9","key":"1494_CR68","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2015-311302","volume":"87","author":"SP Mollan","year":"2016","unstructured":"Mollan SP, Ali F, Hassan-Smith G, Botfield H, Friedman DI, Sinclair AJ (2016) Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatr 87(9):982\u2013992. https:\/\/doi.org\/10.1136\/jnnp-2015-311302","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"5","key":"1494_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","volume":"124","author":"KP Kilgore","year":"2017","unstructured":"Kilgore KP, Lee MS, Leavitt JA, Mokri B, Hodge DO, Frank RD et al (2017) Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmol 124(5):697\u2013700. https:\/\/doi.org\/10.1016\/j.ophtha.2017.01.006","journal-title":"Ophthalmol"},{"issue":"4","key":"1494_CR70","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ajo.2006.12.040","volume":"143","author":"AB Daniels","year":"2007","unstructured":"Daniels AB, Liu GT, Volpe NJ, Galetta SL, Moster ML, Newman NJ et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 143(4):635\u2013641. https:\/\/doi.org\/10.1016\/j.ajo.2006.12.040","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1494_CR71","doi-asserted-by":"publisher","first-page":"e145346","DOI":"10.1172\/jci.insight.145346","volume":"6","author":"CS Westgate","year":"2021","unstructured":"Westgate CS, Botfield HF, Alimajstorovic Z, Yiangou A, Walsh M, Smith G et al (2021) Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 6(10):e145346. https:\/\/doi.org\/10.1172\/jci.insight.145346","journal-title":"JCI Insight."},{"key":"1494_CR72","doi-asserted-by":"publisher","first-page":"c2701","DOI":"10.1136\/bmj.c2701","volume":"341","author":"AJ Sinclair","year":"2010","unstructured":"Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD et al (2010) Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 341:c2701. https:\/\/doi.org\/10.1136\/bmj.c2701","journal-title":"BMJ"},{"key":"1494_CR73","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","volume":"78","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z et al (2021) Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol 78:678. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0659","journal-title":"JAMA Neurol"},{"key":"1494_CR74","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2019.00212","volume":"13","author":"CN Barber","year":"2019","unstructured":"Barber CN, Raben DM (2019) Lipid metabolism crosstalk in the brain: glia and neurons. Front Cell Neurosci 13:212. https:\/\/doi.org\/10.3389\/fncel.2019.00212","journal-title":"Front Cell Neurosci"},{"key":"1494_CR75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcdb.2020.08.012","volume":"112","author":"TJ Tracey","year":"2021","unstructured":"Tracey TJ, Kirk SE, Steyn FJ, Ngo ST (2021) The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Semin Cell Dev Biol 112:69\u201381. https:\/\/doi.org\/10.1016\/j.semcdb.2020.08.012","journal-title":"Semin Cell Dev Biol"},{"issue":"S1","key":"1494_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.08999","volume":"34","author":"AN Fonteh","year":"2020","unstructured":"Fonteh AN, Castor K, Arakaki X, Woldeamanuel Y, Cowan R, Harrington M (2020) Plasma lipid metabolism exemplifies the interoceptive nature of chronic migraine. FASEB J 34(S1):1. https:\/\/doi.org\/10.1096\/fasebj.2020.34.s1.08999","journal-title":"FASEB J"},{"issue":"2","key":"1494_CR77","doi-asserted-by":"publisher","first-page":"E270","DOI":"10.1152\/ajpendo.2001.280.2.E270","volume":"280","author":"A Minnich","year":"2001","unstructured":"Minnich A, Tian N, Byan L, Bilder G (2001) A potent PPAR\u03b1 agonist stimulates mitochondrial fatty acid \u03b2-oxidation in liver and skeletal muscle. Ame J Physiol-Endocrinol Metab 280(2):E270\u2013E279. https:\/\/doi.org\/10.1152\/ajpendo.2001.280.2.E270","journal-title":"Ame J Physiol-Endocrinol Metab"},{"key":"1494_CR78","doi-asserted-by":"publisher","first-page":"3938640","DOI":"10.1155\/2020\/3938640","volume":"2020","author":"L Papetti","year":"2020","unstructured":"Papetti L, Sforza G, Tullo G, Alaimo di Loro P, Moavero R, Ursitti F et al (2020) Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study. Pain Res Manag 2020:3938640. https:\/\/doi.org\/10.1155\/2020\/3938640","journal-title":"Pain Res Manag"},{"key":"1494_CR79","doi-asserted-by":"publisher","unstructured":"Chirchiglia D, Cione E, Caroleo MC, Wang M, Di Mizio G, Faedda N. et al. Effects of add-on ultramicronized n-palmitol ethanol amide in patients suffering of migraine with aura: a pilot study. Front Neurol. 2018;9 (674).\u00a0\u00a0https:\/\/doi.org\/10.3389\/fneur.2018.00674.","DOI":"10.3389\/fneur.2018.00674"},{"key":"1494_CR80","doi-asserted-by":"publisher","first-page":"n1448","DOI":"10.1136\/bmj.n1448","volume":"374","author":"CE Ramsden","year":"2021","unstructured":"Ramsden CE, Zamora D, Faurot KR, MacIntosh B, Horowitz M, Keyes GS et al (2021) Dietary alteration of n-3 and n-6 fatty acids for headache reduction in adults with migraine: randomized controlled trial. BMJ 374:n1448. https:\/\/doi.org\/10.1136\/bmj.n1448","journal-title":"BMJ"},{"key":"1494_CR81","doi-asserted-by":"publisher","first-page":"743171","DOI":"10.1155\/2013\/743171","volume":"2013","author":"G Calviello","year":"2013","unstructured":"Calviello G, Su HM, Weylandt KH, Fasano E, Serini S, Cittadini A (2013) Experimental evidence of \u03c9-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseases. Biomed Res Int 2013:743171. https:\/\/doi.org\/10.1155\/2013\/743171","journal-title":"Biomed Res Int"},{"issue":"4","key":"1494_CR82","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1017\/S1431927612000529","volume":"18","author":"J Vergen","year":"2012","unstructured":"Vergen J, Hecht C, Zholudeva LV, Marquardt MM, Hallworth R, Nichols MG (2012) Metabolic imaging using two-photon excited NADH intensity and fluorescence lifetime imaging. Microsc Microanal\u202f: J Microsc Soc Ame, Microbeam Anal Soc, Microsc Soc Canada 18(4):761\u2013770. https:\/\/doi.org\/10.1017\/S1431927612000529","journal-title":"Microsc Microanal : J Microsc Soc Ame, Microbeam Anal Soc, Microsc Soc Canada"},{"issue":"2","key":"1494_CR83","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/jcbfm.2010.136","volume":"31","author":"F Galeffi","year":"2011","unstructured":"Galeffi F, Somjen GG, Foster KA, Turner DA (2011) Simultaneous monitoring of tissue PO2 and NADH fluorescence during synaptic stimulation and spreading depression reveals a transient dissociation between oxygen utilization and mitochondrial redox state in rat hippocampal slices. J Cereb Blood Flow Metab 31(2):626\u2013639. https:\/\/doi.org\/10.1038\/jcbfm.2010.136","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"1494_CR84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1179\/1743132811Y.0000000077","volume":"34","author":"AP Carlson","year":"2012","unstructured":"Carlson AP, Carter RE, Shuttleworth CW (2012) Vascular, electrophysiological, and metabolic consequences of cortical spreading depression in a mouse model of simulated neurosurgical conditions. Neurol Res 34(3):223\u2013231. https:\/\/doi.org\/10.1179\/1743132811Y.0000000077","journal-title":"Neurol Res"},{"issue":"1","key":"1494_CR85","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10194-011-0300-1","volume":"12","author":"F Li","year":"2011","unstructured":"Li F, Qiu E, Dong Z, Liu R, Wu S, Yu S (2011) Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions. J Headache Pain 12(1):47\u201353. https:\/\/doi.org\/10.1007\/s10194-011-0300-1","journal-title":"J Headache Pain"},{"issue":"11","key":"1494_CR86","doi-asserted-by":"publisher","first-page":"C1017","DOI":"10.1152\/ajpcell.00332.2013","volume":"307","author":"NT Fried","year":"2014","unstructured":"Fried NT, Moffat C, Seifert EL, Oshinsky ML (2014) Functional mitochondrial analysis in acute brain sections from adult rats reveals mitochondrial dysfunction in a rat model of migraine. Am J Physiol Cell Physiol 307(11):C1017\u2013C1030. https:\/\/doi.org\/10.1152\/ajpcell.00332.2013","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"1494_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0022-510x(94)00283-t","volume":"129","author":"A Uncini","year":"1995","unstructured":"Uncini A, Lodi R, Di Muzio A, Silvestri G, Servidei S, Lugaresi A et al (1995) Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci 129(2):214\u2013222. https:\/\/doi.org\/10.1016\/0022-510x(94)00283-t","journal-title":"J Neurol Sci"},{"issue":"6","key":"1494_CR88","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1212\/WNL.42.6.1209","volume":"42","author":"B Barbiroli","year":"1992","unstructured":"Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L et al (1992) Abnormal brain and muscle energy metabolism shown by 31P-magnetic resonance spectroscopy in patients affected by migraine with aura. Neurol 42(6):1209. https:\/\/doi.org\/10.1212\/WNL.42.6.1209","journal-title":"Neurol"},{"issue":"4","key":"1494_CR89","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1600-0404.1992.tb05104.x","volume":"86","author":"T Sacquegna","year":"1992","unstructured":"Sacquegna T, Lodi R, De Carolis P, Tinuper P, Cortelli P, Zaniol P et al (1992) Brain energy metabolism studied by 31P-MR spectroscopy in a case of migraine with prolonged aura. Acta Neurol Scand 86(4):376\u2013380. https:\/\/doi.org\/10.1111\/j.1600-0404.1992.tb05104.x","journal-title":"Acta Neurol Scand"},{"issue":"Pt 12","key":"1494_CR90","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1093\/brain\/awm165","volume":"130","author":"UG Schulz","year":"2007","unstructured":"Schulz UG, Blamire AM, Corkill RG, Davies P, Styles P, Rothwell PM (2007) Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study. Brain 130(Pt 12):3102\u20133110. https:\/\/doi.org\/10.1093\/brain\/awm165","journal-title":"Brain"},{"issue":"4","key":"1494_CR91","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1212\/wnl.44.4.666","volume":"44","author":"P Montagna","year":"1994","unstructured":"Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R et al (1994) 31P-magnetic resonance spectroscopy in migraine without aura. Neurol 44(4):666\u2013669. https:\/\/doi.org\/10.1212\/wnl.44.4.666","journal-title":"Neurol"},{"issue":"12","key":"1494_CR92","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0333102410394675","volume":"31","author":"H Reyngoudt","year":"2011","unstructured":"Reyngoudt H, Paemeleire K, Descamps B, De Deene Y, Achten E (2011) 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia 31(12):1243\u20131253. https:\/\/doi.org\/10.1177\/0333102410394675","journal-title":"Cephalalgia"},{"issue":"3","key":"1494_CR93","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/jcbfm.1993.61","volume":"13","author":"B Barbiroli","year":"1993","unstructured":"Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P et al (1993) Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 13(3):469\u2013474. https:\/\/doi.org\/10.1038\/jcbfm.1993.61","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"1494_CR94","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1093\/brain\/awaa340","volume":"143","author":"M Sassani","year":"2020","unstructured":"Sassani M, Alix JJ, McDermott CJ, Baster K, Hoggard N, Wild JM et al (2020) Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis. Brain 143(12):3603\u20133618. https:\/\/doi.org\/10.1093\/brain\/awaa340","journal-title":"Brain"},{"issue":"3","key":"1494_CR95","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/clinchem\/35.3.392","volume":"35","author":"PA Bottomley","year":"1989","unstructured":"Bottomley PA, Hardy CJ (1989) Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. Clin Chem 35(3):392\u2013395. https:\/\/doi.org\/10.1093\/clinchem\/35.3.392","journal-title":"Clin Chem"},{"issue":"2","key":"1494_CR96","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/sj.cdd.4400937","volume":"9","author":"M Grusch","year":"2002","unstructured":"Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C et al (2002) Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9(2):169\u2013178. https:\/\/doi.org\/10.1038\/sj.cdd.4400937","journal-title":"Cell Death Differ"},{"issue":"6","key":"1494_CR97","doi-asserted-by":"publisher","first-page":"e0178877","DOI":"10.1371\/journal.pone.0178877","volume":"12","author":"M Ekstrand","year":"2017","unstructured":"Ekstrand M, Widell E, Hammar A, Aky\u00fcrek LM, Johansson M, Fagerberg B et al (2017) Depletion of ATP and glucose in advanced human atherosclerotic plaques. PLoS One 12(6):e0178877-e. https:\/\/doi.org\/10.1371\/journal.pone.0178877","journal-title":"PLoS One"},{"issue":"5","key":"1494_CR98","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/00004647-199905000-00007","volume":"19","author":"B Barbiroli","year":"1999","unstructured":"Barbiroli B, Iotti S, Cortelli P, Martinelli P, Lodi R, Carelli V et al (1999) Low brain intracellular free magnesium in mitochondrial cytopathies. J Cereb Blood Flow Metab 19(5):528\u2013532. https:\/\/doi.org\/10.1097\/00004647-199905000-00007","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1494_CR99","doi-asserted-by":"publisher","first-page":"e039358","DOI":"10.1136\/bmjopen-2020-039358","volume":"11","author":"S Sazali","year":"2021","unstructured":"Sazali S, Badrin S, Norhayati MN, Idris NS (2021) Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine\u2014a meta-analysis. BMJ Open 11(1):e039358. https:\/\/doi.org\/10.1136\/bmjopen-2020-039358","journal-title":"BMJ Open"},{"issue":"4","key":"1494_CR100","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1212\/01.WNL.0000151975.03598.ED","volume":"64","author":"PS S\u00e1ndor","year":"2005","unstructured":"S\u00e1ndor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D et al (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurol 64(4):713. https:\/\/doi.org\/10.1212\/01.WNL.0000151975.03598.ED","journal-title":"Neurol"},{"issue":"3","key":"1494_CR101","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/ane.13051","volume":"139","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Li Y, Lu S, Huang W, Di W (2019) Efficacy of CoQ10 as supplementation for migraine: A meta-analysis. Acta Neurol Scand 139(3):284\u2013293. https:\/\/doi.org\/10.1111\/ane.13051","journal-title":"Acta Neurol Scand"},{"key":"1494_CR102","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.eujim.2018.06.009","volume":"21","author":"E Nattagh-Eshtivani","year":"2018","unstructured":"Nattagh-Eshtivani E, Dahri M, Hashemilar M, Tarighat-Esfanjani A (2018) The effect of Coenzyme Q10 supplementation on serum levels of lactate, pyruvate, matrix metalloproteinase 9 and nitric oxide in women with migraine. A double blind, placebo, controlled randomized clinical trial. Eur J Integr Med 21:70\u20136. https:\/\/doi.org\/10.1016\/j.eujim.2018.06.009","journal-title":"Eur J Integr Med"},{"issue":"9","key":"1494_CR103","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/1028415x.2017.1421039","volume":"22","author":"M Dahri","year":"2019","unstructured":"Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M (2019) Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutr Neurosci 22(9):607\u2013615. https:\/\/doi.org\/10.1080\/1028415x.2017.1421039","journal-title":"Nutr Neurosci"},{"issue":"7","key":"1494_CR104","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1468-1331.2004.00813.x","volume":"11","author":"C Boehnke","year":"2004","unstructured":"Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G (2004) High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 11(7):475\u2013477. https:\/\/doi.org\/10.1111\/j.1468-1331.2004.00813.x","journal-title":"Eur J Neurol"},{"issue":"2","key":"1494_CR105","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1212\/wnl.50.2.466","volume":"50","author":"J Schoenen","year":"1998","unstructured":"Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis A randomized controlled trial. Neurol 50(2):466\u2013470. https:\/\/doi.org\/10.1212\/wnl.50.2.466","journal-title":"Neurol"},{"issue":"8","key":"1494_CR106","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1468-2982.2005.00928.x","volume":"25","author":"I Rainero","year":"2005","unstructured":"Rainero I, Limone P, Ferrero M, Valfr\u00e8 W, Pelissetto C, Rubino E et al (2005) Insulin Sensitivity is Impaired in Patients with Migraine. Cephalalgia 25(8):593\u2013597. https:\/\/doi.org\/10.1111\/j.1468-2982.2005.00928.x","journal-title":"Cephalalgia"},{"issue":"10","key":"1494_CR107","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/j.1526-4610.2007.00719.x","volume":"47","author":"C Cavestro","year":"2007","unstructured":"Cavestro C, Rosatello A, Micca G, Ravotto M, Pia Marino M, Asteggiano G et al (2007) Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache: J Head Face Pain 47(10):1436\u201342. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00719.x","journal-title":"J Head Face Pain"},{"issue":"2","key":"1494_CR108","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ene.12289","volume":"21","author":"A Fava","year":"2014","unstructured":"Fava A, Pirritano D, Consoli D, Plastino M, Casalinuovo F, Cristofaro S et al (2014) Chronic migraine in women is associated with insulin resistance: a cross-sectional study. Eur J Neurol 21(2):267\u2013272. https:\/\/doi.org\/10.1111\/ene.12289","journal-title":"Eur J Neurol"},{"issue":"4","key":"1494_CR109","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10194-012-0416-y","volume":"13","author":"SK Bhoi","year":"2012","unstructured":"Bhoi SK, Kalita J, Misra UK (2012) Metabolic syndrome and insulin resistance in migraine. J Headache Pain 13(4):321\u2013326. https:\/\/doi.org\/10.1007\/s10194-012-0416-y","journal-title":"J Headache Pain"},{"issue":"3","key":"1494_CR110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/geno.2001.6647","volume":"78","author":"LC McCarthy","year":"2001","unstructured":"McCarthy LC, Hosford DA, Riley JH, Bird MI, White NJ, Hewett DR et al (2001) Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. Genomics 78(3):135\u2013149. https:\/\/doi.org\/10.1006\/geno.2001.6647","journal-title":"Genomics"},{"issue":"1","key":"1494_CR111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s10194-021-01380-x","volume":"23","author":"J Rosta","year":"2022","unstructured":"Rosta J, T\u00f3th M, Friedrich N, S\u00e1ntha P, Jancs\u00f3 G, Dux M (2022) Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system. J Headache Pain 23(1):7. https:\/\/doi.org\/10.1186\/s10194-021-01380-x","journal-title":"J Headache Pain"},{"issue":"8","key":"1494_CR112","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/sj.bjp.0701779","volume":"123","author":"Y Mimaki","year":"1998","unstructured":"Mimaki Y, Kawasaki H, Okazaki M, Nakatsuma A, Araki H, Gomita Y (1998) Involvement of calcitonin gene-related peptide (CGRP) receptors in insulin-induced vasodilatation in mesenteric resistance blood vessels of rats. Br J Pharmacol 123(8):1684\u20131690","journal-title":"Br J Pharmacol"},{"issue":"16","key":"1494_CR113","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1039\/d1sc01167g","volume":"12","author":"ALH Gray","year":"2021","unstructured":"Gray ALH, Antevska A, Link BA, Bogin B, Burke SJ, Dupuy SD et al (2021) \u03b1-CGRP disrupts amylin fibrillization and regulates insulin secretion: implications on diabetes and migraine. Chem Sci 12(16):5853\u20135864. https:\/\/doi.org\/10.1039\/d1sc01167g","journal-title":"Chem Sci"},{"issue":"5","key":"1494_CR114","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.21873\/invivo.11621","volume":"33","author":"B Zhong","year":"2019","unstructured":"Zhong B, Ma S, Wang DH (2019) TRPV1 mediates glucose-induced insulin secretion through releasing neuropeptides. In Vivo 33(5):1431. https:\/\/doi.org\/10.21873\/invivo.11621","journal-title":"In Vivo"},{"issue":"5","key":"1494_CR115","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0026-0495(99)90058-6","volume":"48","author":"MC Moore","year":"1999","unstructured":"Moore MC, Lin DW, Colburn CA, Goldstein RE, Neal DW, Cherrington AD (1999) Insulin- and glucagon-independent effects of calcitonin gene\u2014related peptide in the conscious dog. Metab - Clin Exp 48(5):603\u2013610. https:\/\/doi.org\/10.1016\/S0026-0495(99)90058-6","journal-title":"Metab - Clin Exp"},{"issue":"2","key":"1494_CR116","doi-asserted-by":"publisher","first-page":"E321","DOI":"10.1152\/ajpendo.1991.260.2.E321","volume":"260","author":"SB Choi","year":"1991","unstructured":"Choi SB, Frontoni S, Rossetti L (1991) Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo. Ame J Physiol-Endocrinol Metab 260(2):E321\u2013E325. https:\/\/doi.org\/10.1152\/ajpendo.1991.260.2.E321","journal-title":"Ame J Physiol-Endocrinol Metab"},{"issue":"6191","key":"1494_CR117","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton B, Cooper GJS (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nat 335(6191):632\u2013635. https:\/\/doi.org\/10.1038\/335632a0","journal-title":"Nat"},{"key":"1494_CR118","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.metop.2020.100060","volume":"8","author":"J Halloran","year":"2020","unstructured":"Halloran J, Lalande A, Zang M, Chodavarapu H, Riera CE (2020) Monoclonal therapy against calcitonin gene-related peptide lowers hyperglycemia and adiposity in type 2 diabetes mouse models. Metab Open 8:100060. https:\/\/doi.org\/10.1016\/j.metop.2020.100060","journal-title":"Metab Open"},{"key":"1494_CR119","doi-asserted-by":"publisher","first-page":"115646","DOI":"10.1016\/j.bone.2020.115646","volume":"143","author":"P K\u00f6hli","year":"2021","unstructured":"K\u00f6hli P, Appelt J, Otto E, Jahn D, Baranowsky A, Bahn A et al (2021) Effects of CGRP receptor antagonism on glucose and bone metabolism in mice with diet-induced obesity. Bone 143:115646. https:\/\/doi.org\/10.1016\/j.bone.2020.115646","journal-title":"Bone"},{"issue":"9","key":"1494_CR120","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1210\/en.2010-0284","volume":"151","author":"CS Walker","year":"2010","unstructured":"Walker CS, Li X, Whiting L, Glyn-Jones S, Zhang S, Hickey AJ et al (2010) mice lacking the neuropeptide \u03b1-calcitonin gene-related peptide are protected against diet-induced obesity. Endocrinol 151(9):4257\u20134269. https:\/\/doi.org\/10.1210\/en.2010-0284","journal-title":"Endocrinol"},{"issue":"5","key":"1494_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0033-1341441","volume":"121","author":"H Tanaka","year":"2013","unstructured":"Tanaka H, Kashiwagi R, Koizumi T (2013) Inhibition of calcitonin gene-related peptide (CGRP) has the potential to extend first-phase insulin secretion. Exp Clin Endocrinol Diabetes 121(5):280\u2013285. https:\/\/doi.org\/10.1055\/s-0033-1341441","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"1494_CR122","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn SE, D\u2019Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr et al (1990) Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39(5):634\u2013638. https:\/\/doi.org\/10.2337\/diab.39.5.634","journal-title":"Diabetes"},{"issue":"3","key":"1494_CR123","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0006-291x(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark P, Wernstedt C, Wilander E, Sletten K (1986) A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 140(3):827\u2013831. https:\/\/doi.org\/10.1016\/0006-291x(86)90708-4","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1494_CR124","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/acn3.197","volume":"2","author":"CS Walker","year":"2015","unstructured":"Walker CS, Eftekhari S, Bower RL, Wilderman A, Insel PA, Edvinsson L et al (2015) A second trigeminal CGRP receptor: function and expression of the AMY1 receptor. Ann Clin Transl Neurol 2(6):595\u2013608. https:\/\/doi.org\/10.1002\/acn3.197","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"1494_CR125","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1177\/0333102420977106","volume":"41","author":"P Irimia","year":"2021","unstructured":"Irimia P, Mart\u00ednez-Valbuena I, M\u00ednguez-Olaondo A, Dom\u00ednguez-Vivero C, S\u00e1nchez-Arias JA, Mart\u00ednez-Vila E et al (2021) Interictal amylin levels in chronic migraine patients: A case-control study. Cephalalgia 41(5):604\u2013612. https:\/\/doi.org\/10.1177\/0333102420977106","journal-title":"Cephalalgia"},{"issue":"6","key":"1494_CR126","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MA, Walker CS, Arngrim N, Rees T, Petersen J et al (2021) Amylin analog pramlintide induces migraine-like attacks in patients. Ann Neurol 89(6):1157\u20131171. https:\/\/doi.org\/10.1002\/ana.26072","journal-title":"Ann Neurol"},{"key":"1494_CR127","doi-asserted-by":"crossref","unstructured":"Rea BJ, Sowers LP, Davison AL, Fairbanks AM, Wattiez A-S, Poolman P, et al. Female mice exhibit a more sensitive automated squint response to pain induced by CGRP and amylin. bioRxiv. 2021:2021.05.26.445893.\u00a0\u00a0https:\/\/journals.lww.com\/pain\/Abstract\/2022\/08000\/Automated_detection_of_squint_as_a_sensitive_assay.12.aspx.","DOI":"10.1101\/2021.05.26.445893"},{"issue":"10","key":"1494_CR128","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.clinthera.2005.10.009","volume":"27","author":"GJ Ryan","year":"2005","unstructured":"Ryan GJ, Jobe LJ, Martin R (2005) Pramlintide in the treatment of type 1 and type 2 diabetes mellitus. Clin Ther 27(10):1500\u20131512. https:\/\/doi.org\/10.1016\/j.clinthera.2005.10.009","journal-title":"Clin Ther"},{"issue":"1","key":"1494_CR129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1468-2982.1994.1401021.x","volume":"14","author":"S Sangiorgi","year":"1994","unstructured":"Sangiorgi S, Mochi M, Riva R, Cortelli P, Monari L, Pierangeli G et al (1994) Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 14(1):21\u201323","journal-title":"Cephalalgia"},{"issue":"1","key":"1494_CR130","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12888-015-0567-x","volume":"15","author":"H Koponen","year":"2015","unstructured":"Koponen H, Kautiainen H, Lepp\u00e4nen E, M\u00e4ntyselk\u00e4 P, Vanhala M (2015) Association between suicidal behaviour and impaired glucose metabolism in depressive disorders. BMC Psychiatry 15(1):163. https:\/\/doi.org\/10.1186\/s12888-015-0567-x","journal-title":"BMC Psychiatry"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-022-01494-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-022-01494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T23:04:13Z","timestamp":1664492653000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-022-01494-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1186\/s10194-022-01494-w","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"O.G reports scientific consultancy fees from Invex therapeutics. G.T reports consultancy fees Novartis, Teva, Allergan, Lilly, Lundbeck, royalties from the Dutch Neurology Handbook, other from CGRP Education and Research Forum and presenter for webinars with Springer Media, Mednet, Ashfield MedComms, Remedica, Cygnea. S.P reports other Invex Therapeutics, other Heidelberg engineering; other from Chugai-Roche Ltd, other from Janssen, other from Allergan, other from Santen, other from Roche, other from Neurodiem, outside the submitted work. A.J.S reports consulting fees and stockholding with Invex therapeutics, during the conduct of the study. Other from Allergan, Amgen, Novartis and Cheisi All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}